NeuroMetrix Inc; | Stock Market News & Stocks to Watch from StraightStocks

NeuroMetrix Ready for Public Sale – Analyst Blog

Zacks Market Commentaries (December 28th, 2009) Writes:

NeuroMetrix, Inc. (NURO) announced that it has filed paperwork to register roughly 4.3 million shares, which constitute approximately 20% of its common stock outstanding, for public sale. These shares are presently owned by one of the Waltham, Mass.-based NeuroMetrix’s largest shareholders, New York hedge fund manager Deerfield Management.

The share registration for public sale conforms to the terms of the private financing agreement with Deerfield, and doesn’t indicate an unexpected exit or unloading of ownership on the part of Deerfield. As per the agreement, NeuroMetrix will not receive any proceeds from the public sale of these newly registered shares. Deerfield acquired NeuroMetrix’s common shares for $2 per share in Sept. 2009. The private placement generated a net $17.3 million for NeuroMetrix. NeuroMetrix designs, develops and sells proprietary medical devices to diagnose neuropathies, which are disturbances of the nervous system. Principally, the company offers physicians an in-office diagnostic system

...

Posted in Investing Lessons, Stocks to Watch | No Comments »

NURO Raises Funds – Analyst Blog

Zacks Market Commentaries (September 9th, 2009) Writes:

NeuroMetrix Inc. (NURO) entered into a private placement transaction with institutional investors for $18.68 million worth of its common stock. Per the agreement, the company will sell 8,816,521 shares and warrants to purchase up to 8,375,695 additional shares of common stock. Each unit, comprising a common stock and a warrant to buy 0.95 share, will carry a purchase price of $2.12. NeuroMetrix expects to close the offer later this week. The warrants will expire five years from their date of issuance. NeuroMetrix designs, develops and sells proprietary medical devices to diagnose neuropathies, which are disturbances of the nervous system. Principally, the company offers physicians an in-office diagnostic system named the NC-stat System. The NC-stat System enables physicians to make rapid and accurate diagnoses of peripheral neuropathies, including carpal tunnel syndrome, low back and leg pain, and diabetic peripheral neuropathy. NeuroMetrix expects to utilize the funds for ...

Posted in Stocks to Watch | No Comments »

PennyOmega.com Stock Report! 7/17/09, ENCO, EBHIQ, RF, ACU, MCHX, TPP, NURO

Penny Omega (July 17th, 2009) Writes:

PennyOmega.com Stock Report!

PennyOmega.com Hot Stock News & Alerts!

Friday, July 17, 2009

PennyOmega.com Stock Report!

**************************************************************

Encorium Group, Inc. (Nasdaq: ENCO), a full service multinational clinical research organization (CRO) that provides design, development, and management capabilities for clinical trials and patient registries to many of the world’s leading pharmaceutical companies, today announced that is has completed the previously announced sale of the Company’s U.S. business to Pierrel Research USA, Inc., a wholly-owned subsidiary of Pierrel SpA, an international contract research organization listed on Milano’s Stock Exchange. The purchase price was $2.7 million, comprised of $80,000 in cash as well as the assumption of $2.6 million in liabilities.

NeuroMetrix, Inc. (Nasdaq: NURO) announced today it plans to

...

Posted in Market Commentary | No Comments »